Integrated Biopharma Inc Q2 FY2026 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2026 Q2 Call date: 2026-02-11 Concluded

Quarter scorecard

Revenue

$11.28M

-10.6% YoY

Diluted EPS

$-0.03

Gross margin

0.3%

-9.0 pp YoY

Net income

-756.9% YoY

Contract Manufacturing $10.92M

-6.4%

Other Nutraceutical Business $360,000

-61.9%